UConn/JAX professor to study repeated DNA
About 50% of human DNA today is made of duplicated sequences that are the remnants of transposition events that took place in our evolutionary history....
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
About 50% of human DNA today is made of duplicated sequences that are the remnants of transposition events that took place in our evolutionary history....
Scientists routinely capture images of the brain in action by focusing on single molecules, cells, or circuits. But visualizing how these tiny units interact to...
Cybrexa Therapeutics reports it is expanding the application of its proprietary alphalex™ platform to include toxin conjugates and additional next generation synthetic lethality targets. Two...
A group of researchers from the UConn School of Medicine have received a nearly $3 million grant from the National Institutes of Health to investigate...
Connecticut Innovations sat down with Per Hellsund, president and CEO of Cybrexa Therapeutics, a bioscience startup whose technology targets cancer tumors. Here’s what he had...
Hyperfine Research has announced a partnership with Penn Medicine. The five-year-old startup, founded by genetics pioneer and New Haven native Jonathan Rothberg and housed in his 4Catalyzer...
BioXcel Therapeutics has reached a general agreement with the FDA on the key elements of the designs for its SERENITY (Sub-Lingual DExmedetomidine in Agitation Associated With SchizophRENIa...
Point72 Ventures reports that it is leading a $17 million fundraising round for a startup that produces software to speed up clinical trials. The startup...
Lewis Bender, CEO of a Connecticut startup called Intensity Therapeutics, feels compelled to cure cancer. “I had friends dying of cancer when I was in...
Over the course of 40 days on the International Space Station (ISS), researchers will determine the effect of microgravity on JAX’s Mighty Mice — genetically...